Nexperia Responds to Dutch Government Suspension and Clarifies Corporate Governance Status

Dutch Government Order
Nexperia announced today that it has been informed of the Dutch Minister of Economic Affairs’ decision to temporarily suspend the order issued under the Dutch Supply Chain Act, citing positive recent developments. Nexperia welcomes the constructive discussions that have taken place between Dutch and Chinese authorities aimed at restoring stability across the supply chain.

While these developments signal meaningful progress, Nexperia emphasizes that a full normalization of supply chain operations will require further cooperation from its entities in China.

Clarification on the Enterprise Chamber’s Ruling
It is important to note that the Enterprise Chamber’s ruling of October 7, 2025, remains fully in effect:

• Under this ruling, Xuezheng Zhang continues to be suspended and no longer serves as Chief Executive Officer of Nexperia.

• The voting rights associated with Nexperia shares indirectly held by Wingtech Technology Co., Ltd. (“Wingtech”) remain under the authority of the court-appointed trustee, meaning Wingtech is not permitted to exercise those rights.

 •Chief Financial Officer Stefan Tilger will continue to serve as acting CEO; Achim Kempe remains Chief Operating Officer; and Chief Legal Officer Ruben Lichtenberg continues as statutory director of Nexperia Holding BV and Nexperia BV. In addition, Guido Dierick has been appointed by the Enterprise Chamber as a non-executive director.

Supply Chain Resilience and Operational Disruptions
The situation regarding supply chain resilience and operational interruptions remains unchanged from our update on Friday, November 14.

We wish to clarify that Nexperia has not halted wafer deliveries entirely. We remain committed to supplying wafers into the value chain and continue to provide alternative delivery pathways to mitigate disruptions and ensure continuity wherever possible. These measures include the direct sale and shipment of wafers to Nexperia customers.

Dedicated teams across the organization are actively developing and implementing practical solutions. We intend to maintain these temporary arrangements until the full turnkey supply chain is restored. All other Nexperia facilities—including those located elsewhere in Europe and across Asia—continue to operate normally. At the same time, we are accelerating capacity expansion at selected sites, with phased ramp-up expected through 2026.

However, Nexperia’s entities in China have ceased operating in accordance with the established corporate governance framework and have disregarded lawful directives issued by Nexperia BV’s global leadership. These actions include:

• Refusing to make payment for wafer deliveries

• Using corporate seals of Chinese entities without authorization or justification

• Opening unauthorized bank accounts and instructing customers to remit payments to those accounts

• Issuing unauthorized letters containing false information to customers, subcontractors, suppliers, and employees

Despite these challenges, Nexperia continued to supply wafers directly throughout October 2025—even after Chinese export restrictions took effect. Based on the volume of wafer shipments during that period, the minimum inventory levels required for proper factory management, and the constraints imposed by Chinese authorities on finished-goods shipments, we estimate that Nexperia China should hold sufficient wafer and product inventory to operate for several months.

Any claims to the contrary raise serious concerns regarding the inventory management practices of Nexperia’s local Chinese leadership. Therefore, any failure to meet shipment commitments rests entirely with Nexperia’s entities in China.